Latest On Meridian Bioscience, Inc (VIVO):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2022-12-14 06:38 EST | News | Meridian Biosciences: Why I Moved On But May Go Back In | N/A |  |
| 2022-12-12 21:17 EST | News | Meridian Bioscience gains after announcing Jan. 31 closing date for sale | N/A | |
| 2022-11-22 09:50 EST | News | Meridian Bioscience Non-GAAP EPS of $0.21, revenue of $65.67M | N/A | |
| 2022-08-05 09:24 EST | News | Meridian Bioscience Non-GAAP EPS of $0.16 misses by $0.01, revenue of $67.8M beats by $1M | N/A | |
| 2022-07-29 19:51 EST | News | FDA re-authorizes emergency use approval for Meridian's Revogene COVID-19 test | N/A | |
| 2022-07-26 22:20 EST | News | Meridian Bioscience: High-Probability Merger Arbitrage | N/A | |
| 2022-07-07 20:01 EST | News | Meridian to be acquired by SD Biosensor, SJL Partners for $1.53B | N/A | |
| 2022-07-07 20:01 EST | News | Meridian Bioscience downgraded at William Blair on $1.53B acquisition | N/A | |
| 2022-06-26 23:08 EST | News | Meridian Bioscience: Correctly Valued | N/A | |
| 2022-06-09 02:10 EST | News | Meridian Bioscience hits 52-week high; stock up 36% YTD | N/A | |
| 2022-05-26 19:25 EST | News | Meridian Biosciences says its qPCR mixes can be used in monkeypox molecular tests | N/A | |
| 2022-05-07 10:12 EST | News | Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q2 2022 Results - Earnings Call Transcript | N/A | |
| 2022-05-07 10:12 EST | News | Meridian Bioscience, Inc. 2022 Q2 - Results - Earnings Call Presentation | N/A | |
| 2022-05-06 09:54 EST | News | Meridian Bioscience Non-GAAP EPS of $0.66 beats by $0.19, revenue of $111.23M beats by $11.68M | N/A | |
| 2022-05-02 10:26 EST | News | Meridian acquires EUPROTEIN to expand recombinant protein capabilities | N/A | |
| 2022-04-07 14:39 EST | News | Meridian Bioscience provides preliminary FQ2 numbers | N/A | |
| 2022-03-14 18:17 EST | News | Meridian Bioscience: Deceptively Priced | N/A | |
| 2022-02-05 04:38 EST | News | Meridian Bioscience rises 5% on boosted fiscal 2022 guidance | N/A | |
| 2022-02-05 04:38 EST | News | Meridian Bioscience, Inc.'s (VIVO) CEO Jack Kenny on Q1 2022 Results - Earnings Call Transcript | N/A | |
| 2022-02-04 11:42 EST | News | Meridian Bioscience Non-GAAP EPS of $0.35, revenue of $88.3M | N/A | |
| 2022-02-03 19:12 EST | News | Meridian Bioscience Q1 2022 Earnings Preview | N/A | |
| 2022-02-01 00:17 EST | News | Meridian awarded additional NIH funding to advance development of Revogene panel | N/A | |
| 2022-01-28 15:11 EST | News | Meridian Bioscience launches saliva-specific mixes for DNA, RNA detection | N/A | |
| 2022-01-27 22:14 EST | News | Meridian Bioscience names new chairman | N/A | |
| 2021-12-03 03:05 EST | News | Meridian Bioscience announces retirement of CFO | N/A | |
| 2021-11-25 07:03 EST | News | Meridian Bioscience Chairman David Phillips retiring | N/A | |
| 2021-11-13 05:57 EST | News | Meridian Bioscience, Inc. (VIVO) CEO Jack Kenny on Q4 2021 Earnings Conference Call - Earnings Call Transcript | N/A | |
| 2021-11-12 10:34 EST | News | Meridian Bioscience EPS beats by $0.03, beats on revenue | N/A | |
| 2021-11-11 15:05 EST | News | Meridian Bioscience Q4 2021 Earnings Preview | N/A | |
| 2021-11-10 17:54 EST | News | Meridian Bioscience gets FDA EUA for Revogene SARS-CoV-2 molecular assay | N/A | |
| 2021-09-22 09:35 EST | News | Meridian Bioscience (VIVO) Presents 23rd Annual Global Investment Virtual Conference - Slideshow | N/A | |
| 2021-09-03 04:17 EST | News | Meridian Bioscience expands recall of LeadCare test kits | N/A | |
| 2021-08-07 08:40 EST | News | Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q3 2021 Results - Earnings Call Transcript | N/A | |
| 2021-08-06 12:39 EST | News | Meridian Bioscience EPS misses by $0.09, misses on revenue | N/A | |
| 2021-08-06 12:39 EST | News | Meridian Bioscience, Inc. 2021 Q3 - Results - Earnings Call Presentation | N/A | |
| 2021-07-24 02:26 EST | News | Meridian Bioscience to acquire North American BreathTek business from Otsuka | N/A | |
| 2021-07-22 07:11 EST | News | AMBA, ZM, IRTC and HOLX among after-hours movers | N/A | |
| 2021-07-22 06:42 EST | News | Meridian resubmits EUA application for Revogene SARS-CoV-2 molecular assay | N/A | |
| 2021-07-22 06:32 EST | News | If The COVID-19 Delta Variant Spreads This Fall, Meridian Is Still A Buy | N/A | |
| 2021-07-22 06:26 EST | News | Meridian Bio sees fiscal Q3 revenue of $63.5M, below consensus | N/A | |
| 2021-07-22 06:26 EST | News | Allied Healthcare Products, SCWorx leads healthcare gainers; Meridian Bioscience, Aridis Pharmaceuticals among major losers | N/A | |
| 2021-05-07 17:24 EST | News | Meridian Bioscience EPS beats by $0.09, misses on revenue | N/A | |
| 2021-05-07 17:23 EST | News | Meridian Bioscience, Inc. (VIVO) CEO John Kenny on Q2 2021 Results - Earnings Call Transcript | N/A | |
| 2021-04-10 06:07 EST | News | Meridian Bioscience: Good Stock, But Margin Of Safety Required | N/A | |
| 2021-03-17 11:04 EST | News | Meridian Bioscience (VIVO) Presents At H.C. Wainwright Global Life Sciences 2021 Virtual Conference - Slideshow | N/A | |
| 2021-03-03 16:41 EST | Analyst Rating | The Analyst Target Price has decreased from $34.33 to $32.67. | Neutral | |
| 2021-02-25 05:14 EST | Analyst Rating | The Analyst Target Price has decreased from $35 to $34.33. | Neutral | |
| 2021-02-23 22:41 EST | News | Meridian Bioscience corrects prior update on Revogene sars-cov-2 EUA withdrawal | N/A | |
| 2021-02-19 17:59 EST | News | Quidel leads a slump in COVID-19 test makers | N/A | |
| 2021-02-16 17:44 EST | News | FDA requests additional information on Meridian Revogene COVID test | N/A | |
About Meridian Bioscience, Inc (VIVO):
Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, including real-time PCR amplification under the Revogene brand; isothermal DNA amplification under the Alethia brand; lateral flow immunoassay using fluorescent chemistry under the Curian brand; rapid immunoassay under the ImmunoCard and ImmunoCard STAT! brands; enzyme-linked immunoassays under the PREMIER brand; anodic stripping voltammetry under the LeadCare and PediaStat brands; and urea breath testing for H. pylori under the BreathID brand. This segment also offers gastrointestinal assays, including tests for C. difficile, H. pylori, and certain foodborne pathogens; respiratory illness assays, such as tests Group A strep, mycoplasma pneumonia, influenza, and pertussis; and blood chemistry assays for testing elevated levels of lead in blood. It sells products through direct sales force and independent distributors to acute care hospitals, reference laboratories, outpatient clinics, and physician office laboratories. The Life Science segment offers bulk antigens, antibodies, PCR/qPCR reagents, nucleotides, and bioresearch reagents used by in vitro diagnostic manufacturers, as well as researchers in immunological and molecular tests for human, animal, plant, and environmental applications. The company has a strategic collaboration with DiaSorin Inc. to sell H. pylori tests. Meridian Bioscience, Inc. was incorporated in 1976 and is headquartered in Cincinnati, Ohio.
General
- Name Meridian Bioscience, Inc
- Symbol VIVO
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryDiagnostics & Research
- Full Time Employees 750
- Last Split Factor3:2
- Last Split Date2007-05-14
- Fiscal Year EndSeptember
- IPO Date1986-08-08
- Gic SectorHealth Care
- Gic GroupHealth Care Equipment & Services
- Gic IndustryHealth Care Equipment & Supplies
- Gic SubIndustryHealth Care Supplies
- Web URLhttp://www.meridianbioscience.com
View More
Valuation
- Trailing PE 15.69
- Forward PE 17.04
- Price/Sales (Trailing 12 Mt.) 3.63
- Price/Book (Most Recent Quarter) 3.87
- Enterprise Value Revenue 3.62
- Enterprise Value EBITDA 10.18
View More
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate $1.66
- Next Year EPS Estimate $1.27
- Next Quarter EPS Estimate $0.34
- Profit Margin 23%
- Operating Margin 31%
- Return on Assets 15%
- Return on Equity 29%
- Revenue 299.16 million
- Earnings Per Share $1.61
- Revenue Per Share $6.97
- Gross Profit 156.25 million
- Quarterly Earnings Growth 95.9%
View More
Highlights
- Market Capitalization 1.09 billion
- EBITDA 105.81 million
- PEG Ratio 1.33
- Analyst Target Price $32.67
- Book Value Per Share $6.47
View More
Share Statistics
- Shares Outstanding 43.15 million
- Shares Float 38.44 million
- % Held by Insiders 70%
- % Held by Institutions 94.07%
- Shares Short 3.17 million
- Shares Short Prior Month 3.28 million
- Short Ratio 3.23
- Short % of Float 10%
- Short % of Shares Outstanding 7%
View More
Technicals
- Beta 0.53
- 52 Week High $30.65
- 52 Week Low $6.51
- 50 Day Moving Average 24.06
- 200 Day Moving Average 19.91
View More
Dividends
- Dividend Date 2019-02-14
- ExDividend Date 2019-02-01
- Dividend Per Share $N/A
- Dividend Yield 0%
View More
Meridian Bioscience, Inc (VIVO) Dividend Calendar:
VIVO's last dividend payment was made to shareholders on February 14, 2019.
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
Meridian Bioscience, Inc (VIVO) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
| Quarter Date | Report Date | Actual Revenue | Reported EPS | EPS Estimate | Deviation from Estimate |
|---|---|---|---|---|---|
| 2020-12-31 | 2021-02-05 | $92.92 million | $0.65 | $0.42 | 53.56% |
| 2020-09-30 | 2020-11-13 | $64.15 million | $0.19 | $0.14 | 38.99% |
| 2020-06-30 | 2020-08-07 | $N/A | $0.55 | $0.24 | 134.04% |
| 2020-03-31 | 2020-05-08 | $57.3 million | $0.23 | $0.08 | 187.5% |
| 2019-12-31 | 2020-02-07 | $47.42 million | $0.10 | $0.06 | 66.67% |
| 2019-09-30 | 2019-11-07 | $50.85 million | $0.13 | $0.09 | 40.54% |
| 2019-06-30 | 2019-07-30 | $48.44 million | $0.16 | $0.09 | 72.97% |
| 2019-03-31 | 2019-04-30 | $50.25 million | $0.19 | $0.15 | 26.67% |
| 2018-12-31 | 2019-01-24 | $51.48 million | $0.20 | $0.17 | 15.94% |
| 2018-09-30 | 2018-11-08 | $53.1 million | $0.20 | $0.16 | 26.58% |
| 2018-06-30 | 2018-07-31 | $51.74 million | $0.18 | $0.18 | 1.12% |
| 2018-03-31 | 2018-04-26 | $56.45 million | $0.21 | $0.21 | 0% |
| 2017-12-31 | 2018-01-25 | $52.28 million | $0.15 | $0.14 | 4.68% |
| 2017-09-30 | 2017-11-09 | $49.7 million | $0.15 | $0.14 | 5.63% |
| 2017-06-30 | 2017-07-27 | $50.14 million | $0.16 | $0.17 | -4.25% |
| 2017-03-31 | 2017-04-27 | $54.13 million | $0.22 | $0.19 | 13.23% |
| 2016-12-31 | 2017-01-25 | $46.81 million | $0.15 | $0.20 | -24.36% |
| 2016-09-30 | 2016-11-10 | $47 million | $0.14 | $0.14 | -2.98% |
| 2016-06-30 | 2016-07-28 | $50.67 million | $0.21 | $0.22 | -5.28% |
| 2016-03-31 | 2016-04-28 | $51.26 million | $0.24 | $0.24 | -1.19% |
| 2015-12-31 | 2016-01-27 | $47.16 million | $0.21 | $0.21 | 2.09% |
| 2015-09-30 | 2015-11-05 | $47.07 million | $0.20 | $0.21 | -4.76% |
| 2015-06-30 | 2015-07-23 | $48.2 million | $0.22 | $0.22 | 0% |
| 2015-03-31 | 2015-04-23 | $51.55 million | $0.24 | $0.24 | 0% |
| 2014-12-31 | 2015-01-22 | $48.01 million | $0.19 | $0.19 | 0% |
| 2014-09-30 | 2014-11-06 | $46.69 million | $0.20 | $0.22 | -9.09% |
| 2014-06-30 | 2014-07-24 | $47.21 million | $0.21 | $0.23 | -8.7% |
| 2014-03-31 | 2014-04-24 | $50.13 million | $0.24 | $0.27 | -11.11% |
| 2013-12-31 | 2014-01-22 | $44.79 million | $0.18 | $0.18 | 0% |
| 2013-09-30 | 2013-11-07 | $48.96 million | $0.22 | $0.23 | -4.35% |
| 2013-06-30 | 2013-07-25 | $47.11 million | $0.24 | $0.22 | 9.09% |
| 2013-03-31 | 2013-04-25 | $47.27 million | $0.24 | $0.24 | 0% |
| 2012-12-31 | 2013-01-23 | $45.35 million | $0.20 | $0.19 | 5.26% |
| 2012-09-30 | 2012-11-08 | $43.48 million | $0.21 | $0.19 | 10.53% |
| 2012-06-30 | 2012-07-26 | $41.92 million | $0.21 | $0.22 | -4.55% |
| 2012-03-31 | 2012-04-26 | $47.24 million | $0.23 | $0.21 | 9.52% |
| 2011-12-31 | 2012-01-25 | $40.08 million | $0.17 | $0.19 | -10.53% |
| 2011-09-30 | 2011-11-10 | $41.35 million | $0.18 | $0.19 | -5.26% |
| 2011-06-30 | 2011-07-21 | $40.05 million | $0.17 | $0.21 | -19.05% |
| 2011-03-31 | 2011-04-21 | $41.06 million | $0.20 | $0.20 | 0% |
| 2010-12-31 | 2011-01-20 | $37.26 million | $0.15 | $0.19 | -21.05% |
| 2010-09-30 | 2010-11-11 | $35.54 million | $0.15 | $0.18 | -16.67% |
| 2010-06-30 | 2010-07-20 | $33.86 million | $0.16 | $0.18 | -11.11% |
| 2010-03-31 | 2010-04-20 | $31.15 million | $0.15 | $0.14 | 7.14% |
| 2009-12-31 | 2010-01-21 | $42.46 million | $0.22 | $0.22 | 0% |
| 2009-09-30 | 2009-11-12 | $42.46 million | $0.22 | $0.21 | 4.76% |
| 2009-06-30 | 2009-07-16 | $38.24 million | $0.21 | $0.19 | 10.53% |
| 2009-03-31 | 2009-04-16 | $33.28 million | $0.18 | $0.21 | -14.29% |
| 2008-12-31 | 2009-01-22 | $34.29 million | $0.20 | $0.20 | 0% |
| 2008-09-30 | 2008-11-12 | $36.48 million | $0.19 | $0.18 | 5.56% |
| 2008-06-30 | 2008-07-17 | $33.07 million | $0.19 | $0.19 | 0% |
| 2008-03-31 | 2008-04-17 | $36.25 million | $0.18 | $0.19 | -5.26% |
| 2007-12-31 | 2008-01-22 | $33.85 million | $0.18 | $0.17 | 5.88% |
| 2007-09-30 | 2007-11-14 | $32.39 million | $0.16 | $0.15 | 6.67% |
| 2007-06-30 | 2007-07-19 | $29.76 million | $0.16 | $0.15 | 6.67% |
| 2007-03-31 | 2007-04-19 | $32.09 million | $0.15 | $0.14 | 7.14% |
| 2006-12-31 | 2007-01-18 | $28.72 million | $0.14 | $0.12 | 16.67% |
| 2006-09-30 | 2006-11-15 | $28.65 million | $0.12 | $0.11 | 9.09% |
| 2006-06-30 | 2006-07-20 | $26.58 million | $0.12 | $0.11 | 9.09% |
| 2006-03-31 | 2006-04-20 | $28.27 million | $0.12 | $0.10 | 20% |
| 2005-12-31 | 2006-01-19 | $24.91 million | $0.10 | $0.09 | 11.11% |
| 2005-09-30 | 2005-11-10 | $25.02 million | $0.10 | $0.08 | 25% |
| 2005-06-30 | 2005-07-21 | $25.42 million | $0.10 | $0.07 | 42.86% |
| 2005-03-31 | 2005-04-21 | $23.69 million | $0.09 | $0.08 | 12.5% |
| 2004-12-31 | 2005-01-20 | $18.84 million | $0.06 | $0.08 | -25% |
| 2004-09-30 | 2004-11-17 | $22.24 million | $0.08 | $0.06 | 33.33% |
| 2004-06-30 | 2004-07-22 | $18.26 million | $0.06 | $0.06 | 0% |
| 2004-03-31 | 2004-04-22 | $20.94 million | $0.07 | $0.06 | 16.67% |
| 2003-12-31 | 2004-01-22 | $18.17 million | $0.05 | $0.05 | 0% |
| 2003-09-30 | 2003-11-18 | $17.16 million | $0.05 | $0.04 | 25% |
| 2003-06-30 | 2003-07-24 | $15.69 million | $0.05 | $0.04 | 25% |
| 2003-03-31 | 2003-04-24 | $16.91 million | $0.06 | ||
| 2002-12-31 | 2003-01-21 | $16.1 million | $0.04 | ||
| 2002-09-30 | 2002-11-13 | $15.56 million | $0.05 | $0.05 | 0% |
| 2002-06-30 | 2002-06-30 | $14.9 million | $0.05 | ||
| 2002-03-31 | 2002-03-31 | $15.09 million | $0.04 | ||
| 2001-12-31 | 2001-12-31 | $13.56 million | $0.04 | ||
| 2001-09-30 | 2001-09-30 | $13.5 million | $0.01 | ||
| 2001-06-30 | 2001-06-30 | $13.91 million | -$0.02 | ||
| 2001-03-31 | 2001-03-31 | $13.87 million | -$0.05 | ||
| 2000-12-31 | 2000-12-31 | $15.25 million | -$0.25 | ||
| 2000-09-30 | 2000-11-16 | $13.85 million | -$0.01 | $0.07 | -114.29% |
| 2000-06-30 | 2000-07-21 | $14.34 million | $0.06 | $0.06 | 0% |
| 2000-03-31 | 2000-04-20 | $14.58 million | $0.06 | $0.06 | 0% |
| 1999-12-31 | 2000-01-20 | $0.04 | $0.04 | 0% | |
| 1999-09-30 | 1999-11-17 | $0.06 | $0.05 | 20% | |
| 1999-06-30 | 1999-07-22 | $0.05 | $0.05 | 0% | |
| 1999-03-31 | 1999-04-21 | $0.05 | $0.04 | 25% | |
| 1998-12-31 | 1999-01-28 | $0.03 | $0.03 | 0% | |
| 1998-09-30 | 1998-11-13 | $0.03 | $0.03 | 0% | |
| 1998-06-30 | 1998-07-27 | $0.04 | $0.06 | -33.33% | |
| 1998-03-31 | 1998-04-21 | $0.05 | $0.04 | 25% | |
| 1997-12-31 | 1998-01-21 | $0.03 | $0.03 | 0% | |
| 1997-09-30 | 1997-11-12 | $0.07 | $0.06 | 16.67% | |
| 1997-06-30 | 1997-07-21 | $0.05 | $0.05 | 0% | |
| 1997-03-31 | 1997-04-14 | $0.04 | $0.05 | -20% | |
| 1996-12-31 | 1997-01-20 | $0.03 | $0.03 | 0% | |
| 1996-09-30 | 1996-11-11 | $0.05 | $0.05 | 0% | |
| 1996-06-30 | 1996-07-22 | $0.05 | $0.04 | 25% | |
| 1996-03-31 | 1996-04-19 | $0.04 | $0.04 | 0% | |
| 1995-12-31 | 1996-01-23 | $0.02 | $0.02 | 0% | |
| 1995-03-31 | 1995-04-20 | $0.04 | $0.03 | 33.33% | |
| 1994-12-31 | 1995-01-24 | $0.01 | $0.01 | 0% | |
| 1994-03-31 | 1994-05-10 | $0.02 | $0.03 | -33.33% |
Meridian Bioscience, Inc (VIVO) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Meridian Bioscience, Inc (VIVO) Chart:
Meridian Bioscience, Inc (VIVO) News:
Below you will find a list of latest news for Meridian Bioscience, Inc (VIVO) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Meridian Bioscience, Inc (VIVO) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
Latest VIVO Trades:
| Date | Shares | Price |
|---|---|---|
| Jun 13, 2022 7:59 PM EST | 25 | $26.69 |
| Jun 13, 2022 7:59 PM EST | 5 | $26.69 |
| Jun 13, 2022 7:59 PM EST | 12 | $26.69 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.7 |
| Jun 13, 2022 7:59 PM EST | 100 | $26.7 |
Meridian Bioscience, Inc (VIVO) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|---|---|---|
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/0001127602-20-020774-index.htm |
| 2019-01-31 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000021545719002263/0000215457-19-002263-index.htm |
| 2020-02-04 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000083423720002222/0000834237-20-002222-index.htm |
| 2018-02-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000030/0000892251-18-000030-index.htm |
| 2018-03-21 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000035/0000892251-18-000035-index.htm |
| 2018-04-26 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000046/0000892251-18-000046-index.htm |
| 2018-05-25 | SD | https://www.sec.gov/Archives/edgar/data/794172/000089225118000053/0000892251-18-000053-index.htm | |
| 2018-07-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000058/0000892251-18-000058-index.htm |
| 2018-09-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000069/0000892251-18-000069-index.htm |
| 2018-11-01 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000078/0000892251-18-000078-index.htm |
| 2018-12-12 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225118000086/0000892251-18-000086-index.htm |
| 2019-01-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225119000004/0000892251-19-000004-index.htm |
| 2019-01-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225119000006/0000892251-19-000006-index.htm |
| 2019-04-02 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225119000027/0000892251-19-000027-index.htm |
| 2019-05-23 | SD | https://www.sec.gov/Archives/edgar/data/794172/000089225119000043/0000892251-19-000043-index.htm | |
| 2019-10-04 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225119000057/0000892251-19-000057-index.htm |
| 2020-01-27 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225120000002/0000892251-20-000002-index.htm |
| 2020-01-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000089225120000004/0000892251-20-000004-index.htm |
| 2020-05-27 | SD | https://www.sec.gov/Archives/edgar/data/794172/000089225120000026/0000892251-20-000026-index.htm | |
| 2018-02-09 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000093247118004089/0000932471-18-004089-index.htm |
| 2018-03-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000093247118005342/0000932471-18-005342-index.htm |
| 2019-02-11 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000093247119005614/0000932471-19-005614-index.htm |
| 2018-02-14 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000103738918000067/0001037389-18-000067-index.htm |
| 2019-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000103738919000257/0001037389-19-000257-index.htm |
| 2020-02-13 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000103738920000287/0001037389-20-000287-index.htm |
| 2020-02-12 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000110465920017155/0001104659-20-017155-index.htm |
| 2018-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218008295/0001127602-18-008295-index.htm |
| 2018-04-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218015305/0001127602-18-015305-index.htm |
| 2018-06-06 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218020116/0001127602-18-020116-index.htm |
| 2018-08-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218026375/0001127602-18-026375-index.htm |
| 2018-09-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218028277/0001127602-18-028277-index.htm |
| 2018-10-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218029515/0001127602-18-029515-index.htm |
| 2018-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218032337/0001127602-18-032337-index.htm |
| 2018-11-14 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218032958/0001127602-18-032958-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033646/0001127602-18-033646-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033647/0001127602-18-033647-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033648/0001127602-18-033648-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033649/0001127602-18-033649-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033650/0001127602-18-033650-index.htm |
| 2018-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218033651/0001127602-18-033651-index.htm |
| 2018-11-21 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760218034166/0001127602-18-034166-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002777/0001127602-19-002777-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002778/0001127602-19-002778-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002779/0001127602-19-002779-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002780/0001127602-19-002780-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002781/0001127602-19-002781-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002782/0001127602-19-002782-index.htm |
| 2019-01-28 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219002783/0001127602-19-002783-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219007866/0001127602-19-007866-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219007867/0001127602-19-007867-index.htm |
| 2019-02-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219007870/0001127602-19-007870-index.htm |
| 2019-05-09 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219017855/0001127602-19-017855-index.htm |
| 2019-05-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219018293/0001127602-19-018293-index.htm |
| 2019-05-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219019121/0001127602-19-019121-index.htm |
| 2019-05-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219019555/0001127602-19-019555-index.htm |
| 2019-08-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219026924/0001127602-19-026924-index.htm |
| 2019-09-23 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219028923/0001127602-19-028923-index.htm |
| 2019-10-15 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219030443/0001127602-19-030443-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219031602/0001127602-19-031602-index.htm |
| 2019-11-04 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219031603/0001127602-19-031603-index.htm |
| 2019-11-07 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219032143/0001127602-19-032143-index.htm |
| 2019-11-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219032417/0001127602-19-032417-index.htm |
| 2019-11-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219032589/0001127602-19-032589-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219033153/0001127602-19-033153-index.htm |
| 2019-11-19 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219033156/0001127602-19-033156-index.htm |
| 2019-11-20 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219033333/0001127602-19-033333-index.htm |
| 2019-11-25 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760219033636/0001127602-19-033636-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002832/0001127602-20-002832-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002833/0001127602-20-002833-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002834/0001127602-20-002834-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002835/0001127602-20-002835-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002837/0001127602-20-002837-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002838/0001127602-20-002838-index.htm |
| 2020-01-31 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220002840/0001127602-20-002840-index.htm |
| 2020-02-12 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220005010/0001127602-20-005010-index.htm |
| 2020-02-24 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220007112/0001127602-20-007112-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220007839/0001127602-20-007839-index.htm |
| 2020-02-26 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220007840/0001127602-20-007840-index.htm |
| 2020-03-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220010224/0001127602-20-010224-index.htm |
| 2020-03-13 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220010524/0001127602-20-010524-index.htm |
| 2020-03-17 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220011012/0001127602-20-011012-index.htm |
| 2020-07-02 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/0001127602-20-020774-index.htm |
| 2020-08-11 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220023319/0001127602-20-023319-index.htm |
| 2020-08-12 | 4/A | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000112760220023455/0001127602-20-023455-index.htm |
| 2018-04-25 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000114036118019524/0001140361-18-019524-index.htm |
| 2018-06-06 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000114036118027541/0001140361-18-027541-index.htm |
| 2018-05-10 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312518158486/0001193125-18-158486-index.htm |
| 2018-08-09 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312518243530/0001193125-18-243530-index.htm |
| 2018-11-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312518321924/0001193125-18-321924-index.htm |
| 2018-11-29 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/794172/000119312518337257/0001193125-18-337257-index.htm |
| 2018-12-13 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/794172/000119312518348327/0001193125-18-348327-index.htm |
| 2019-01-24 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519015342/0001193125-19-015342-index.htm |
| 2019-02-11 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312519034030/0001193125-19-034030-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519127438/0001193125-19-127438-index.htm |
| 2019-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519127444/0001193125-19-127444-index.htm |
| 2019-05-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312519139559/0001193125-19-139559-index.htm |
| 2019-05-31 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519162257/0001193125-19-162257-index.htm |
| 2019-06-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519164163/0001193125-19-164163-index.htm |
| 2019-06-06 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519166746/0001193125-19-166746-index.htm |
| 2019-06-25 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519180727/0001193125-19-180727-index.htm |
| 2019-07-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519206185/0001193125-19-206185-index.htm |
| 2019-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312519214674/0001193125-19-214674-index.htm |
| 2019-08-14 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519220799/0001193125-19-220799-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519286647/0001193125-19-286647-index.htm |
| 2019-11-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312519287124/0001193125-19-287124-index.htm |
| 2019-11-26 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] | https://www.sec.gov/Archives/edgar/data/794172/000119312519300565/0001193125-19-300565-index.htm |
| 2019-12-18 | DEF 14A | Other definitive proxy statements | https://www.sec.gov/Archives/edgar/data/794172/000119312519316898/0001193125-19-316898-index.htm |
| 2020-02-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520027468/0001193125-20-027468-index.htm |
| 2020-02-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312520027769/0001193125-20-027769-index.htm |
| 2020-02-20 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520043212/0001193125-20-043212-index.htm |
| 2020-04-03 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520097334/0001193125-20-097334-index.htm |
| 2020-04-30 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520128802/0001193125-20-128802-index.htm |
| 2020-05-08 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520136998/0001193125-20-136998-index.htm |
| 2020-05-08 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312520137039/0001193125-20-137039-index.htm |
| 2020-07-28 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520201092/0001193125-20-201092-index.htm |
| 2020-08-07 | 8-K | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520212515/0001193125-20-212515-index.htm |
| 2020-08-07 | 10-Q | Quarterly report [Sections 13 or 15(d)] | https://www.sec.gov/Archives/edgar/data/794172/000119312520212537/0001193125-20-212537-index.htm |
| 2020-08-10 | 8-K/A | Current report | https://www.sec.gov/Archives/edgar/data/794172/000119312520213198/0001193125-20-213198-index.htm |
| 2020-10-26 | SC 13G | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000119380520001313/0001193805-20-001313-index.htm |
| 2018-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000139834418002271/0001398344-18-002271-index.htm |
| 2019-02-14 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000139834419002732/0001398344-19-002732-index.htm |
| 2019-12-10 | SC 13G/A | Statement of acquisition of beneficial ownership by individuals | https://www.sec.gov/Archives/edgar/data/794172/000139834419022319/0001398344-19-022319-index.htm |
| 2018-09-24 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761918003044/0001567619-18-003044-index.htm |
| 2019-01-07 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761919000660/0001567619-19-000660-index.htm |
| 2020-05-21 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761920010863/0001567619-20-010863-index.htm |
| 2020-07-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761920013869/0001567619-20-013869-index.htm |
| 2020-07-29 | 3 | Initial statement of beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761920013871/0001567619-20-013871-index.htm |
| 2020-07-29 | 4 | Statement of changes in beneficial ownership of securities | https://www.sec.gov/Archives/edgar/data/794172/000156761920013872/0001567619-20-013872-index.htm |
| 2020-02-05 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/794172/999999999720000484/9999999997-20-000484-index.htm |
| 2020-02-28 | SEC STAFF | SEC Staff Letter: REDACTED EXHIBIT | https://www.sec.gov/Archives/edgar/data/794172/999999999720001080/9999999997-20-001080-index.htm |
Meridian Bioscience, Inc (VIVO) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Meridian Bioscience, Inc (VIVO). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.Insider Ownership: 70%Institutional Ownership: 9407%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-01-29 | Catherine Sazdanoff | Director | Buy | 3,186.00 | 11,867.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002838/0001127602-20-002838-index.htm | ||
| 2019-05-16 | James M. Anderson | Director | Buy | 5,000.00 | 11.37 | 56,855.00 | 11,981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219019121/0001127602-19-019121-index.htm |
| 2020-02-24 | John McCune Jr. Rice | Director | Buy | 3,000.00 | 7.52 | 22,547.10 | 12,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220007839/0001127602-20-007839-index.htm |
| 2020-01-29 | John McIlwraith | Director | Buy | 3,186.00 | 12,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002834/0001127602-20-002834-index.htm | ||
| 2020-01-29 | Dwight E Ellingwood | Director | Buy | 3,186.00 | 12,733.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002833/0001127602-20-002833-index.htm | ||
| 2020-01-29 | James M. Anderson | Director | Buy | 3,186.00 | 15,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002832/0001127602-20-002832-index.htm | ||
| 2018-11-15 | SUSAN ROLIH | EVP, Global Reg & Quality Syst | Buy | 12,500.00 | 171,089.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033650/0001127602-18-033650-index.htm | ||
| 2020-02-25 | John McIlwraith | Director | Buy | 5,000.00 | 7.59 | 37,949.50 | 17,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220007840/0001127602-20-007840-index.htm |
| 2018-11-15 | MELISSA LUEKE | Exec VP, CFO | Buy | 12,500.00 | 173,898.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033649/0001127602-18-033649-index.htm | ||
| 2019-11-05 | John P. Kenny | Chief Executive Officer | Buy | 99,505.00 | 178,324.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219032143/0001127602-19-032143-index.htm | ||
| 2019-11-08 | John P. Kenny | Chief Executive Officer | Buy | 20,000.00 | 7.73 | 154,588.00 | 198,324.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219032417/0001127602-19-032417-index.htm |
| 2020-02-21 | John P. Kenny | Chief Executive Officer | Buy | 10,000.00 | 7.65 | 76,546.00 | 208,324.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220007112/0001127602-20-007112-index.htm |
| 2018-11-15 | Eric S. Rasmussen | EVP, Bus. Development/Strategy | Buy | 17,500.00 | 22,500.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033647/0001127602-18-033647-index.htm | ||
| 2020-03-12 | John P. Kenny | Chief Executive Officer | Buy | 30,000.00 | 5.78 | 173,541.00 | 238,324.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220010524/0001127602-20-010524-index.htm |
| 2018-11-20 | John McCune Jr. Rice | Director | Buy | 2,000.00 | 13.55 | 27,100.00 | 3,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218034166/0001127602-18-034166-index.htm |
| 2015-02-10 | Dwight E Ellingwood | Director | Buy | 33.00 | 18.20 | 600.59 | 3,013.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2015-05-11 | Dwight E Ellingwood | Director | Buy | 32.00 | 18.51 | 592.47 | 3,045.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2015-08-10 | Dwight E Ellingwood | Director | Buy | 32.00 | 18.69 | 598.12 | 3,077.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2015-11-23 | Dwight E Ellingwood | Director | Buy | 32.00 | 19.27 | 616.51 | 3,109.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2016-02-12 | Dwight E Ellingwood | Director | Buy | 32.00 | 19.62 | 627.83 | 3,141.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2016-05-16 | Dwight E Ellingwood | Director | Buy | 33.00 | 19.06 | 628.99 | 3,174.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2019-09-16 | Bryan T Baldasare | Interim CFO & Chief Acctg Off | Buy | 1,200.00 | 32,071.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219028923/0001127602-19-028923-index.htm | ||
| 2019-05-13 | DAVID PHILLIPS | Director | Buy | 5,000.00 | 11.40 | 57,015.00 | 38,371.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219018293/0001127602-19-018293-index.htm |
| 2018-02-23 | John McIlwraith | Director | Buy | 1,000.00 | 14.03 | 14,034.30 | 4,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218008295/0001127602-18-008295-index.htm |
| 2020-01-29 | Felicia Williams | Director | Buy | 3,186.00 | 4,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002840/0001127602-20-002840-index.htm | ||
| 2019-11-12 | DAVID PHILLIPS | Director | Buy | 10,000.00 | 8.06 | 80,626.00 | 48,616.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219032589/0001127602-19-032589-index.htm |
| 2018-11-15 | LOURDES WELTZIEN | EVP, Life Science | Buy | 12,500.00 | 49,185.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033651/0001127602-18-033651-index.htm | ||
| 2018-06-04 | Eric S. Rasmussen | EVP, Bus. Development/Strategy | Buy | 5,000.00 | 5,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218020116/0001127602-18-020116-index.htm | ||
| 2020-03-10 | Bryan T Baldasare | Exec VP & CFO | Buy | 1,000.00 | 6.98 | 6,981.00 | 51,637.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220010224/0001127602-20-010224-index.htm |
| 2019-10-31 | Bryan T Baldasare | Exec VP & CFO | Buy | 20,534.00 | 52,605.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219031602/0001127602-19-031602-index.htm | ||
| 2020-03-10 | Bryan T Baldasare | Exec VP & CFO | Buy | 1,000.00 | 6.96 | 6,955.00 | 52,637.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220010224/0001127602-20-010224-index.htm |
| 2020-06-30 | Bryan T Baldasare | Exec VP & CFO | Buy | 1,500.00 | 19.71 | 29,565.00 | 54,137.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220020774/0001127602-20-020774-index.htm |
| 2020-03-16 | Felicia Williams | Director | Buy | 1,550.00 | 6.02 | 9,331.00 | 5,717.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220011012/0001127602-20-011012-index.htm |
| 2019-05-22 | John McCune Jr. Rice | Director | Buy | 2,000.00 | 11.26 | 22,516.40 | 5,981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219019555/0001127602-19-019555-index.htm |
| 2018-08-24 | John McIlwraith | Director | Buy | 2,000.00 | 15.63 | 31,250.00 | 6,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218026375/0001127602-18-026375-index.htm |
| 2016-08-15 | Dwight E Ellingwood | Director | Buy | 32.00 | 19.50 | 624.03 | 6,206.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2016-11-28 | Dwight E Ellingwood | Director | Buy | 38.00 | 17.07 | 648.47 | 6,244.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2018-11-15 | John P. Kenny | Chief Executive Officer | Buy | 25,000.00 | 63,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033646/0001127602-18-033646-index.htm | ||
| 2018-11-13 | LAWRENCE BALDINI | EVP, Global Operations | Sell | 9,876.00 | 19.55 | 193,047.16 | 66,253.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218032958/0001127602-18-032958-index.htm |
| 2019-10-31 | LOURDES WELTZIEN | EVP, Life Science | Buy | 20,534.00 | 68,953.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219031603/0001127602-19-031603-index.htm | ||
| 2017-02-13 | Dwight E Ellingwood | Director | Buy | 41.00 | 12.93 | 530.07 | 7,305.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2017-05-15 | Dwight E Ellingwood | Director | Buy | 36.00 | 14.90 | 536.30 | 7,341.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2017-08-14 | Dwight E Ellingwood | Director | Buy | 39.00 | 13.94 | 543.58 | 7,380.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2017-11-28 | Dwight E Ellingwood | Director | Buy | 38.00 | 14.56 | 553.31 | 7,418.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2018-02-13 | Dwight E Ellingwood | Director | Buy | 39.00 | 14.13 | 551.11 | 7,457.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2018-05-15 | Dwight E Ellingwood | Director | Buy | 40.00 | 13.88 | 555.18 | 7,497.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2018-08-16 | Dwight E Ellingwood | Director | Buy | 38.00 | 14.91 | 566.68 | 7,535.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2018-11-12 | LAWRENCE BALDINI | EVP, Global Operations | Sell | 25,225.00 | 19.35 | 488,181.95 | 76,129.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218032958/0001127602-18-032958-index.htm |
| 2018-11-15 | LAWRENCE BALDINI | EVP, Global Operations | Buy | 12,500.00 | 78,753.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218033648/0001127602-18-033648-index.htm | ||
| 2018-10-04 | Dwight E Ellingwood | Director | Buy | 1,000.00 | 12.80 | 12,800.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218029515/0001127602-18-029515-index.htm |
| 2018-11-05 | John McIlwraith | Director | Buy | 2,000.00 | 12.80 | 25,600.00 | 8,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760218032337/0001127602-18-032337-index.htm |
| 2019-05-08 | John P. Kenny | Chief Executive Officer | Buy | 20,000.00 | 11.49 | 229,744.00 | 83,000.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219017855/0001127602-19-017855-index.htm |
| 2020-01-29 | DAVID PHILLIPS | Director | Buy | 3,186.00 | 8,432.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002835/0001127602-20-002835-index.htm | ||
| 2020-07-28 | Anthony P III Bihl | Director | Buy | 851.00 | 851.00 | https://www.sec.gov/Archives/edgar/data/794172/000156761920013872/0001567619-20-013872-index.htm | ||
| 2018-11-28 | Dwight E Ellingwood | Director | Buy | 31.00 | 18.42 | 571.07 | 8,566.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219007865/0001127602-19-007865-index.htm |
| 2020-01-29 | John McCune Jr. Rice | Director | Buy | 3,186.00 | 9,167.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760220002837/0001127602-20-002837-index.htm | ||
| 2019-01-24 | Catherine Sazdanoff | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002782/0001127602-19-002782-index.htm | ||
| 2019-01-24 | DAVID PHILLIPS | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002780/0001127602-19-002780-index.htm | ||
| 2019-01-24 | Dwight E Ellingwood | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002778/0001127602-19-002778-index.htm | ||
| 2019-01-24 | Felicia Williams | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002783/0001127602-19-002783-index.htm | ||
| 2019-01-24 | James M. Anderson | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002777/0001127602-19-002777-index.htm | ||
| 2019-01-24 | John McCune Jr. Rice | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002781/0001127602-19-002781-index.htm | ||
| 2019-01-24 | John McIlwraith | Director | Buy | 981.00 | 981.00 | https://www.sec.gov/Archives/edgar/data/794172/000112760219002779/0001127602-19-002779-index.htm |